Neurochemical Systems and Signaling

From Molecules to Networks

Ghulam Md Ashraf

$326

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

CRC Press
30 June 2023

Forensic science; Neurology & clinical neurophysiology; Neurosciences; Molecular biology; Pharmaceutical technology

The human brain is made up of billions of neurons that communicate with each other through chemical messengers, which are referred to as neuroactive substances. These neuroactive substances include neurotransmitters, neuromodulators, and neurohormones. Some neurotransmitters also act as neuromodulators and neurohormones. It is unlikely that there would ever be a consensus about the meanings of these neuroactive substances, including neurotransmitters, since the term ‘neurotransmitter’ has traditionally been used very loosely indeed, to include neurotransmitters, neurohormones, and neuromodulators. Any alterations in the functioning of these neuroactive substances can cause diseases.

The brain is the ultimate center that regulates all neurological and behavioral aspects of the body through neuronal communications mediated via various neurochemicals. Thus, neurological and psychiatric disorders are, in most cases, the result of disturbed neurochemical balance. Besides the multifaceted involvement of billions of neuronal cells, the central nervous system is a complex organization with a diverse number of neurotransmitter systems, as compared to the autonomic nervous system, in which the parasympathetic system works on the ‘rest and digest’ phenomenon, and the sympathetic system works on the ‘fight or flight’ phenomenon. There are more than 20 neurotransmitter systems and multiple receptors for each neurotransmitter. Any alterations in neurochemical balance are expressed in the form of neurological or psychiatric disorders such as epilepsy, Parkinson’s disease, Alzheimer’s disease, psychosis, depression, etc. Acetylcholine, noradrenaline, dopamine, and 5-HT are of the utmost importance among neurotransmitters for their profound role in the pathogenesis of various neurological and psychiatric disorders in humans. Yet the involvement of various proteins and peptides, such as neurotrophic factors, growth factors, and endogenous chemical compounds, cannot be ignored.

Day by day, the suffering of people due to an imbalance of neurotransmitters is increasing. Various factors, for example stress, diet, genetics, and toxins such as alcohol and nicotine, contribute to this imbalance. This imbalance may lead to mental health complaints. The main purpose of this book is to give a comprehensive overview of the neurological diseases associated with neurochemical imbalances. This book will help readers gain a comprehensive understanding of neuronal signaling and related neurological disorders, as well as status and future opportunities and challenges. It will provide a brief account of neurotransmission, as either a study or high-yield revision aid.

Edited by: Ghulam Md Ashraf
Imprint: CRC Press
Country of Publication: United Kingdom
Dimensions: Height: 280mm, Width: 210mm,
Weight: 712g
ISBN: 9780367210625
ISBN 10: 0367210622
Pages: 280
Publication Date: 30 June 2023
Audience: Professional and scholarly , Undergraduate
Format: Hardback
Publisher's Status: Active

Section I. Transmitters and Systems Chapter 1: Adrenergic Neurotransmission Chapter 2: Cholinergic Neurotransmission Chapter 3: Dopamine Signaling Section II. Neurochemical Signaling and Pathologies Chapter 4: Neurochemical Signaling in Alzheimer’s Disease Chapter 5: Alzheimer’s Disease: Pathogenesis and Therapeutics Advancements Targeting Potential Neurotransmitters and Neuronal Peptides Chapter 6: Cholinergic Neurotransmission System: Signaling Pathways and Their Role in Parkinson’s Disease Chapter 7: Neurochemical Alterations in Parkinson's Disease Chapter 8: Therapeutic Targets and Neurochemical Signaling in Huntington’s Disease Chapter 9: Schizophrenia: Neurochemical Insight into a Mind’s Faulty Dimension Chapter 10: Neurochemical Signaling in Depression: Impact of Target-Based Pharmaceuticals Chapter 11: Role of Endocannabinoids in Neurocognitive Dysfunctions Chapter 12: Role of Glutaminergic System in Schizophrenia Chapter 13: Mania: Developmental Considerations from Diagnosis to Treatment Chapter 14: Myasthenia Gravis: Molecular Pathogenesis and Therapeutic Advances Section III. Typical Neurochemical Processes Chapter 15: Neurogenesis in the Embryonic and Adult Brain Chapter 16: Neuronal Proliferation and Associated Diseases Chapter 17: Neurobiology in Correlation with Romantic Attraction Chapter 18: Neurobiology of love: A Comprehensive Analysis

Dr. Ghulam Md Ashraf is working as an Associate Professor in the Department of Medical Laboratory Sciences, College of Health Sciences, and Sharjah Institute for Medical Research, University of Sharjah, Sharjah United Arab Emirates. He has a PhD degree in Biochemistry with over twelve years of teaching and research experience in various disciplines of biological and medical sciences. Dr. Ashraf has taught various subjects like Biochemistry, Biology, Clinical Biochemistry, Cell Biology, Genetics, Immunology, Intellectual Property Rights, Introduction to Research, Molecular Biology, Neurology, Recombinant DNA, and Research Methods Technology at graduate and post-graduate levels. His primary fields of research are biochemistry and neurology, currently focusing on understanding the molecular and behavioral mechanism of effects of anti-diabetic drugs in pyschotic and dementia conditions. Dr. Ashraf’s lab is currently investigating the effect of anti-diabetic drugs in the possible attenuation/reversal of anti-psychotic drugs induced weight gain in psychotic conditions. He is also investigating molecular and behavioral mechanisms of novel therapeutic combinations in multiple sclerosis and Alzheimer’s disease. Dr. Ashraf has published 398 research articles (citations: 9928, H-index: 53, i10 index: 208) and have been involved in 25 research grants [4 ongoing (1 PI, 3 CoI) and 21 completed (17 PI, 4 CoI)]. He has supervised 3 PhD, 2 masters and 7 bachelor students in their research projects. Dr. Ashraf has served as examiner of 9 PhD and master theses and have assessed 4 research grant applications. Dr. Ashraf is also involved extensively in editorial roles in renowned scientific journals like Journal of Advanced Research (Associate Editor), Scientific Reports (Senior EBM), PLoS One (Academic Editor), Current Neuropharmacology (Section Editor) and Disease Markers (Academic Editor). He has to his credit 359 Publons verified editor records, and 609 Publons verified reviewer records. Dr. Ashraf has been involved as guest editor of 21 special issues in reputed international journals. He is professionally associated with the Royal Society of Medicine (Fellow), Royal Society of Biology (Member), American Society for Biochemistry and Molecular Biology (Member) and Canadian Association of Neuroscience (Member). For his scientific contributions, Dr. Ashraf was approved as a subject of biographical record in Marquis Who's Who in the World (2020). Dr. Ashraf has been recognized as Expertscape World Expert in Alzheimer’s disease and Neurodegenerative Disorders. Most recently, he has been listed in Top 2% Scientists Worldwide for two consecutive years (2020 and 2021), announced by Stanford-Elsevier BV (Baas et al., 2021). Orcid: https://orcid.org/0000-0002-9820-2078 Scopus: https://www.scopus.com/authid/detail.uri?authorId=16444016700 Web of Science: https://www.webofscience.com/wos/author/record/H-9485-2012 Google scholar: http://scholar.google.com/citations?user=-fOCOTQAAAAJ&hl=en